beta-lactams has been researched along with cefoxitin in 45 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (cefoxitin) | Trials (cefoxitin) | Recent Studies (post-2010) (cefoxitin) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 2,131 | 362 | 328 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (37.78) | 18.7374 |
| 1990's | 1 (2.22) | 18.2507 |
| 2000's | 2 (4.44) | 29.6817 |
| 2010's | 21 (46.67) | 24.3611 |
| 2020's | 4 (8.89) | 2.80 |
| Authors | Studies |
|---|---|
| Dornbusch, K; Nord, CE; Olsson, B | 1 |
| Andrews, JM; Gillett, AP; Wise, R | 1 |
| Richmond, MH | 1 |
| Neu, HC | 1 |
| Mitsuhashi, S; Une, T | 1 |
| Stapley, EO; Zimmerman, SB | 1 |
| Andrew, JH; Greenwood, D | 1 |
| Hashizume, T; Sawai, T; Yamaguchi, A | 1 |
| McNamara, BT; Meyer, RD; Pasiecznik, KA | 1 |
| Aznar, J; Borobio, MV; Garcia, F; Jimenez, R; Perea, EJ | 1 |
| Frère, JM; Ghuysen, JM; Kelly, JA; Klein, D | 1 |
| Maskell, JP; Nasu, M; Williams, JD; Williams, RJ | 1 |
| Crokaert, F; Labbé, M; Lismont, MJ; Van der Linden, MP; Yourassowsky, E | 1 |
| Dornbusch, K; Nord, CE; Olsson-Lijequist, B | 1 |
| Goering, RV; Sanders, CC; Sanders, WE | 1 |
| Fass, RJ | 1 |
| Baker, S; Cadge, B; Durham, SR; Gillett, AP; Wise, R | 1 |
| Amicosante, G; Fattorini, L; Franceschini, N; Orefici, G; Scopetti, F | 1 |
| Beadle, BM; Nicholas, RA; Shoichet, BK | 1 |
| Cui, L; Hiramatsu, K; Kuroda, H; Kuroda, M | 1 |
| Hasegawa, T; Inuzuka, K; Ohkura, T; Ohta, M; Okamoto, A; Sanzen, I; Tatsumi, N; Yamada, K | 1 |
| Davies, C; Nicholas, RA; Nicola, G; Pratt, RF; Tomberg, J | 1 |
| Badiou, C; Benito, Y; Bes, M; Boisset, S; Bowden, MG; Cheung, AL; Choudhury, P; Dumitrescu, O; Etienne, J; Lina, G; Vandenesch, F; Wolz, C | 1 |
| Hu, RM; Tsai, JJ; Tsai, MJ; Yang, TC | 1 |
| Chau, F; Fantin, B; Le, P; Lefort, A; Lepeule, R; Massias, L; Nucci, A; Ruppé, E | 1 |
| Banerjee, R; Enthaler, N; Fernandez, MG; Graml, C; Greenwood-Quaintance, KE; Patel, R | 1 |
| Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C | 1 |
| Dien Bard, J; Gold, HS; Hindler, JA; Limbago, B | 1 |
| Gentry, CA; Williams, RJ | 1 |
| Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
| Child, J; Crombleholme, T; Hurst, AL; Olson, D; Parker, SK; Pyle, L; Ranade, D; Somme, S; Stamatoiu, A | 1 |
| Dunyach-Remy, C; Lavigne, JP; Mesureur, J; Ngba Essebe, C; Nicolas-Chanoine, MH; Pagès, JM; Pantel, A; Sotto, A | 1 |
| Ariano, RE; Calic, D; Lawson, C; Lipman, J; Roberts, JA; Zelenitsky, SA; Zhanel, GG | 1 |
| Gennimata, D; Kiriazopoulos, E; Lombardo, K; Panderi, I; Panteri-Petratou, E; Vonaparti, A; Vourna, P; Zaharaki, S | 1 |
| Aguilera Rossi, CG; Ayala Serrano, JA; Gómez-Puertas, P | 1 |
| Alp, E; Badal, R; Gulay, Z; Koksal, I; Korten, V; Lob, S; Mete, B; Mulazimoglu, L; Oguz, VA; Tabak, F; Unal, S; Yilmaz, G; Zarakolu, P | 1 |
| Bian, L; Chen, X; Li, Y; Yang, J; Zhang, Y | 1 |
| Archambault, M; Gentilini, ER; Jacques, M; Srednik, ME | 1 |
| Keller, PM; Müller, DM; Rominski, A; Sander, P; Schulthess, B | 1 |
| Hao, W; He, Y; Mafiz, A; Perera, LN; Sun, S; Xiao, S; Zhang, W; Zhang, Y; Zhou, K | 1 |
| Shang, X; Sun, Y; Wang, L; Wang, X; Yang, F; Zhang, S | 1 |
| Daher, W; Johansen, MD; Kozikowski, AP; Kremer, L; Onajole, OK; Ordway, D; Raynaud, C; Roquet-Banères, F; Stec, J | 1 |
| Alharbi, M; Alharbi, O; Biboy, J; Derrick, JP; Gallagher, LA; Grunert, T; Ingmer, H; Liu, H; Mayer, K; McBain, AJ; Mikkelsen, K; Nøhr-Meldgaard, K; O'Gara, JP; Sirisarn, W; Vestergaard, M; Vollmer, W; Xia, G | 1 |
| Dilworth, T; Hernandez, BN; Kesner, J; Mercier, RC; Ryan, K; Thelen, H | 1 |
| Aldana-Mejía, JA; Bastos, JK; Júnior, AF; Pereira, AFM; Rall, VLM; Ripari, N; Sforcin, JM | 1 |
45 other study(ies) available for beta-lactams and cefoxitin
| Article | Year |
|---|---|
beta-lactamases in bacteroides.
Topics: Amidohydrolases; Anti-Bacterial Agents; Bacteriological Techniques; Bacteroides; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Cefamandole; Cefoxitin; Cell Wall; Cephalosporinase; Cephalosporins; Furans; Humans; Isoelectric Focusing; Penicillin G; Penicillin Resistance; Penicillinase; Penicillins; Prevotella melaninogenica; Species Specificity | 1978 |
The in vitro activity of mezlocillin when combined with cefoxitin or clavulanic acid.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactams; Cefoxitin; Drug Interactions; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Staphylococcus aureus | 1979 |
beta-lactamase insensitive or inhibitory beta-lactams: two approaches to the challenge of ampicillin-resistant E. coli.
Topics: Amidohydrolases; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cefoxitin; Cephalosporinase; Cephalosporins; Chemical Phenomena; Chemistry; Escherichia coli; Furans; Hydrolysis; Penicillin Resistance; Penicillinase | 1978 |
A new beta-lactam antibiotic: is it a major advance?
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefoxitin; Enterobacteriaceae Infections; Humans | 1979 |
Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
Topics: Animals; Bacteria; beta-Lactams; Cefazolin; Cefoxitin; Cephalosporinase; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Drug Stability; Enterobacteriaceae; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Penicillinase | 1977 |
Relative morphological effects induced by cefoxitin and other beta-lactam antibiotics in vitro.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefoxitin; Cephalosporins; Enterobacteriaceae | 1976 |
Susceptibility of cefotetan and Sch 34343 to beta-lactamases produced by strains of Bacteroides that hydrolyse cefoxitin or imipenem.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamases; beta-Lactams; Cefotetan; Cefoxitin; Cephamycins; Hydrolysis; Imipenem; Lactams; Microbial Sensitivity Tests; Thienamycins | 1987 |
Outer membrane permeability of imipenem in comparison with other beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; Cell Membrane Permeability; Citrobacter; Cloxacillin; Enterobacter; Escherichia coli; Imipenem; Microbial Sensitivity Tests; Moxalactam; Thienamycins | 1986 |
In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to Amikacin and selected new beta-lactam agents.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefoxitin; Cephalothin; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Kanamycin; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa | 1982 |
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefaclor; Cefoperazone; Cefotaxime; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Cephamycins; Culture Media; Microbial Sensitivity Tests; Moxalactam | 1980 |
Interaction between non-classical beta-lactam compounds and the Zn2+-containing G and serine R61 and R39 D-alanyl-D-alanine peptidases.
Topics: Actinomycetaceae; Amdinocillin; beta-Lactams; Carboxypeptidases; Cefoxitin; Cephalosporins; Clavulanic Acid; Drug Interactions; Endopeptidases; Enzyme Inhibitors; Imipenem; Kinetics; Penicillanic Acid; Penicillins; Quinoxalines; Serine-Type D-Ala-D-Ala Carboxypeptidase; Streptomyces; Zinc | 1981 |
In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; beta-Lactams; Cefotaxime; Cefoxitin; Cefsulodin; Cephalosporins; Cephamycins; Imipenem; Lincomycin; Metronidazole; Moxalactam | 1981 |
The effect of beta-lactam antibiotics on the growth curves of Bacteroides fragilis, obtained with the MS-2 system.
Topics: Anaerobiosis; Bacteroides fragilis; beta-Lactams; Carbenicillin; Cefoxitin; Cell Division; Cephamycins; Dose-Response Relationship, Drug; Kinetics; Microbial Sensitivity Tests; Moxalactam; Penicillin G | 1981 |
Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamases; beta-Lactams; Cefoxitin; Drug Resistance, Microbial; Microbial Sensitivity Tests | 1980 |
In vitro antagonism of beta-lactam antibiotics by cefoxitin.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefoxitin; Microbial Sensitivity Tests | 1982 |
In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
Topics: Amdinocillin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cefoxitin; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillins; Pseudomonas | 1980 |
The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Azlocillin; beta-Lactams; Blister; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Floxacillin; Humans; Imidazolidines; Male; Penicillins; Protein Binding | 1980 |
Non-inducible, mainly cell-associated beta-lactamase from Nocardia asteroides strain 108.
Topics: Amoxicillin; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefoxitin; Detergents; Hydrolysis; Isoelectric Point; Mutagenesis; Mutation; Nocardia asteroides; Penicillin G | 1997 |
Interaction energies between beta-lactam antibiotics and E. coli penicillin-binding protein 5 by reversible thermal denaturation.
Topics: Acylation; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Carrier Proteins; Cefoxitin; Circular Dichroism; Cloxacillin; Escherichia coli; Hexosyltransferases; Imipenem; Models, Chemical; Moxalactam; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Protein Denaturation; Spectrometry, Fluorescence; Temperature; Thermodynamics | 2001 |
Subinhibitory concentrations of beta-lactam induce haemolytic activity in Staphylococcus aureus through the SaeRS two-component system.
Topics: Bacterial Proteins; beta-Lactams; Cefoxitin; Gene Expression Regulation, Bacterial; Hemolysin Proteins; Humans; Mutation; Oligonucleotide Array Sequence Analysis; Signal Transduction; Staphylococcus aureus; Transcription Factors; Virulence; Virulence Factors | 2007 |
Evaluation of selection media for the detection of borderline MRSA.
Topics: Agar; Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactams; Cefoxitin; Culture Media; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Penicillin-Binding Proteins; RNA, Ribosomal, 16S | 2010 |
Crystal structures of covalent complexes of β-lactam antibiotics with Escherichia coli penicillin-binding protein 5: toward an understanding of antibiotic specificity.
Topics: Acylation; Anti-Bacterial Agents; beta-Lactams; Cefoxitin; Cloxacillin; Crystallography, X-Ray; Escherichia coli; Hydrolysis; Imipenem; Penicillin-Binding Proteins | 2010 |
Beta-lactams interfering with PBP1 induce Panton-Valentine leukocidin expression by triggering sarA and rot global regulators of Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; beta-Lactams; Cefaclor; Cefotaxime; Cefoxitin; Exotoxins; Female; Gene Expression Regulation, Bacterial; Imipenem; Leukocidins; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Oxacillin; Penicillin-Binding Proteins; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Trans-Activators | 2011 |
Induction of a secretable beta-lactamase requires a long lag time in Xanthomonas campestris pv. campestris str. 17.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefoxitin; Culture Media; Gene Expression Regulation, Bacterial; Time Factors; Transcription, Genetic; Xanthomonas campestris | 2011 |
Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Cefoxitin; Ceftriaxone; Conjugation, Genetic; Disease Models, Animal; Drug Administration Schedule; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Kidney; Mice; Microbial Sensitivity Tests; Mutation Rate; Plasmids; Urinary Bladder; Urinary Tract Infections | 2012 |
Combinations of cefoxitin plus other β-lactams are synergistic in vitro against community associated methicillin-resistant Staphylococcus aureus.
Topics: beta-Lactams; Cefoxitin; Community-Acquired Infections; Cross Infection; Drug Synergism; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections | 2013 |
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index | 2014 |
Rationale for eliminating Staphylococcus breakpoints for β-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftaroline.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cefoxitin; Ceftaroline; Cephalosporins; Humans; Microbial Sensitivity Tests; Oxacillin; Penicillins; Staphylococcal Infections; Staphylococcus; United States; United States Food and Drug Administration | 2014 |
Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ertapenem; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; United States; United States Department of Veterans Affairs | 2015 |
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2016 |
Once-Daily Ceftriaxone Plus Metronidazole Versus Ertapenem and/or Cefoxitin for Pediatric Appendicitis.
Topics: Abdominal Abscess; Adolescent; Appendectomy; Appendicitis; beta-Lactams; Cefoxitin; Ceftriaxone; Child; Child, Preschool; Cost Savings; Cost-Benefit Analysis; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Ertapenem; Female; Humans; Infant; Laparoscopy; Male; Metronidazole; Retrospective Studies; Treatment Outcome; Young Adult | 2017 |
Modulation of Membrane Influx and Efflux in Escherichia coli Sequence Type 131 Has an Impact on Bacterial Motility, Biofilm Formation, and Virulence in a Caenorhabditis elegans Model.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biofilms; Biological Transport; Caenorhabditis elegans; Cefoxitin; Chloramphenicol; Ertapenem; Escherichia coli; Mutation; Virulence | 2016 |
Integrated pharmacokinetic-pharmacodynamic modelling to evaluate antimicrobial prophylaxis in abdominal surgery.
Topics: Abdomen; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteria, Anaerobic; Bacteroides fragilis; beta-Lactams; Cefoxitin; Clindamycin; Computer Simulation; Drug Dosage Calculations; Ertapenem; Female; Gentamicins; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Monte Carlo Method; Surgical Wound Infection | 2016 |
Quantification of three beta-lactam antibiotics in breast milk and human plasma by hydrophilic interaction liquid chromatography/positive-ion electrospray ionization mass spectrometry.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefoxitin; Cefuroxime; Chromatography, Liquid; Female; Humans; Hydrophobic and Hydrophilic Interactions; Limit of Detection; Milk, Human; Spectrometry, Mass, Electrospray Ionization | 2017 |
In vivo functional and molecular characterization of the Penicillin-Binding Protein 4 (DacB) of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Carboxypeptidases; Cefoxitin; Cross Infection; DNA, Bacterial; Endopeptidases; Enzyme Activation; Escherichia coli; Escherichia coli Proteins; Models, Molecular; Penicillin-Binding Proteins; Peptidoglycan; Pseudomonas aeruginosa; Recombinant Proteins | 2016 |
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefoxitin; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Turkey; Urinary Tract Infections | 2017 |
Binding of TEM-1 beta-lactamase to beta-lactam antibiotics by frontal affinity chromatography.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; Cephalexin; Chromatography, Affinity; Enzymes, Immobilized; Gram-Negative Bacteria; Penicillin G; Protein Binding; Thermodynamics | 2017 |
Detection of a mecC-positive Staphylococcus saprophyticus from bovine mastitis in Argentina.
Topics: Animals; Anti-Bacterial Agents; Argentina; Bacterial Proteins; beta-Lactams; Cattle; Cefoxitin; Drug Resistance, Bacterial; Female; Lincosamides; Macrolides; Mastitis, Bovine; Microbial Sensitivity Tests; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus saprophyticus | 2017 |
Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; Cephalosporins; Drug Stability; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Mutation; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Thienamycins | 2017 |
Case study on the soil antibiotic resistome in an urban community garden.
Topics: Ampicillin; Anti-Bacterial Agents; Antiporters; Bacterial Proteins; beta-Lactams; Cefoxitin; Ceftriaxone; Chloramphenicol; Cities; Drug Resistance, Multiple, Bacterial; Escherichia coli Proteins; Gardens; Gene Expression; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kanamycin; Metagenome; Microbial Sensitivity Tests; Penicillins; Quinolones; Soil Microbiology | 2018 |
Short communication: N-Acetylcysteine-mediated augmentation of β-lactam antibacterial activity against methicillin-resistant Staphylococcus aureus isolated from bovine mastitis cases.
Topics: Acetylcysteine; Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Cattle; Cefoxitin; Female; Mastitis, Bovine; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Penicillin G | 2019 |
Synergistic Interactions of Indole-2-Carboxamides and β-Lactam Antibiotics against Mycobacterium abscessus.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefoxitin; Colony Count, Microbial; Drug Synergism; Humans; Imipenem; Indoles; Macrophages; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2020 |
The Novel Membrane-Associated Auxiliary Factors AuxA and AuxB Modulate β-lactam Resistance in MRSA by stabilizing Lipoteichoic Acids.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Cefoxitin; Cell Wall; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Larva; Lipopolysaccharides; Membrane Proteins; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Animal; Moths; Mutation; Octoxynol; Oxacillin; Penicillin-Binding Proteins; Peptidoglycan; Phenotype; Staphylococcal Infections; Teichoic Acids; Virulence | 2021 |
MIC Discrepancies between Parenteral and Oral Anti-Staphylococcal Beta-Lactams among MSSA.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefoxitin; Cephalexin; Dicloxacillin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monobactams; Oxacillin; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Brazilian red propolis in combination with β-lactams exerts an efficient antibacterial action over methicillin-resistant Staphylococcus aureus (MRSA) strains.
Topics: Anti-Bacterial Agents; beta-Lactams; Brazil; Cefoxitin; Drug Synergism; Imipenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Propolis | 2023 |